The Company Meridian Bioscience Inc. (United States), is listed on Nasdaq with a market value of $ 1.49 Billion, having an equity of $ 340.54 Millions.
With a total of 560 employees, the company is listed in the sector of Health and categorized in industry of Medical Supplies and Equipment.
In the last 12 months the Company had a revenue of $ 301.58 Millions, which generated a loss in the amount of $ -2.70 Millions.
As for its main indicators, the Company has a P/E ratio of -551.87, a P/BV ratio of 4.38 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker VIVO.